Of note, AML cell lines with FLT3-ITD mutations (as MV4-11, MOLM13 and MOLM14) [5] were more vulnerable to the genetic depletion of NDUFA6, NDUFC1 and SDHA (Fig. 6A-C). The gene discussed is NDUFC1; the disease is acute myeloid leukemia.